Skip to main content

Table 2 Baseline comparison of relevant indexes before and after menopause

From: Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women

  Premenopausal t/Z/χ 2 P Postmenopausal t/Z/χ 2 P
Non-diabetic
(n = 182)
Diabetic
(n = 25)
Non-diabetic
(n = 586)
Diabetic
(n = 2434)
Age (years) 46.65 ± 1.83 46.68 ± 1.38 0.083 0.934 60.05 ± 7.39 62.93 ± 7.75 8.158 < 0.001
BMI (kg/m2) 23.83 (21.975, 25.79) 24.91 (23.05, 27.78) −1.896 0.058 24.27 (22.22,26.31) 25.39 (23.03, 27.99) −7.181 < 0.001
WC (cm) 78 (73, 81) 81 (78, 90.5) −2.553 0.011 81 (77, 84.25) 84 (80, 91) −10.08 < 0.001
SBP (mmHg) 127.5 (120, 136.25) 130 (119.5, 162.5) −1.324 0.185 134 (123, 149) 140 (130, 158.25) −7.422 < 0.001
DBP (mmHg) 79 (70, 85) 85 (72.5, 92) −1.616 0.106 81 (74, 90) 84 (76, 93.25) −3.258 0.001
HbA1c (%) 5.4 (5.1, 5.7) 6.4 (5.6, 8.7) −5.001 < 0.001 5.6 (5.3, 5.9) 6.8 (6.1, 7.8) −29.113 < 0.001
FPG (mmol/L) 5.18 (4.88, 5.48) 5.43 (5.06, 8.52) −2.949 0.003 5.35 (5.06, 5.74) 6.975 (5.67, 8.53) −23.812 < 0.001
TC (mmol/L) 4.735 (4.21, 5.36) 4.51 (4.15, 5.6) −0.429 0.668 5.24 (4.68, 5.8) 5.2 (4.63, 5.88) −0.014 0.989
TG (mmol/L) 1.465 (1.12, 1.99) 1.55 (1.17, 2.17) −0.815 0.415 1.73 (1.37, 2.28) 1.92 (1.5, 2.61) −5.974 < 0.001
LDL-C (mmol/L) 2.445 (2.09, 2.76) 2.32 (1.915, 3.14) −0.249 0.803 2.73 (2.31, 3.2) 2.75 (2.28, 3.2) −0.010 0.992
UA (μmol/L) 236.8 (203.18,267.13) 227.8 (197.4, 269.7) −0.274 0.784 251.9 (213.3294.5) 261.05 (218.5324.3) −3.537 < 0.001
BUN (mg/dl) 4.405 (3.73, 5.22) 4.91 (3.75, 6.34) −1.472 0.141 4.93 (4.21, 5.77) 5.055 (4.37, 6.01) −2.808 0.005
ALT (U/L) 18 (14, 25) 19 (14, 25) −0.483 0.629 20 (16, 25) 22 (18, 29) −6.021 < 0.001
AST (U/L) 18 (15.75, 23) 16 (15.5, 21.5) −0.662 0.508 20 (18, 24) 20 (17, 24) −0.491 0.623
TP (g/L) 72.8 (70.6, 75) 75 (73.15, 77.55) −3.084 0.002 74 (71.6, 76.3) 74.4 (72.2, 77) −3.131 0.002
TBIL (μmol/L) 9.995 (7.84, 13.59) 9.15 (7.81, 13.56) −0.564 0.572 10.845 (8.66,13.69) 10.99 (8.68, 14.03) −0.620 0.535
eGFR (ml/min) 105.48 (97.45,108.81) 108.13 (98.56,111.67) −1.718 0.086 92.93 (82.12,99.73) 92.66 (79.75, 99.41) −1.068 0.286
Smoking n (%) 4 (2.2) 0 (0) 0.560 0.454 34 (1.4) 8 (1.4) 0.003 0.953
Drinking n (%) 4 (2.2) 2 (8) 2.630 0.105 32 (1.3) 2 (0.3) 4.020 0.045
History of Hypertension n (%) 17 (9.3) 8 (32) 10.630 0.001 751 (20.9) 293 (50) 76.536 < 0.001
History of CHD n (%) 4 (2.2) 2 (8) 2.630 0.110 115 (4.7) 54 (9.2) 18.030 < 0.001
History of sleep disorders n (%) 3 (1.6) 0 (0) 0.420 0.520 68 (2.8) 31 (5.3) 9.283 0.002
  1. Data are presented as the mean ± SD, number (as %), or median (range), as appropriate. Comparisons between the three groups were made using ANOVA or Fisher’s exact test, as appropriate International system of units (SI) conversion: BMI body mass index, CHD Coronary heart disease, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglycerides, UA uric acid, BUN blood urea nitrogen, e-GFR estimated glomerular filtration rate, FPG fasting plasma glucose, LDL-C low-density lipoprotein cholesterol, TBIL Total bilirubin, TP Total Protein